Zhong Guo Jing Ji Wang·2026-03-14 07:27Core Viewpoint - Guangzhou Kolarity Medical Equipment Co., Ltd. has been approved for IPO on the Beijing Stock Exchange, marking it as the 34th company to pass the review in 2026, with a focus on radiation therapy and rehabilitation medical devices [1][2]. Company Overview - Kolarity specializes in providing medical device solutions for radiation therapy and rehabilitation, focusing on the development, production, and sales of radiation positioning devices and rehabilitation aids [1]. - The company is primarily controlled by Lijin Technology, which holds 43.13% of the shares, and the actual controllers are Zhan Derun and his spouse Li Li, who collectively control 64.93% of the voting rights [1]. IPO Details - Kolarity plans to publicly issue up to 14.8 million shares, with a potential over-allotment option of up to 2.22 million shares, bringing the total issuance to a maximum of 17.02 million shares [2]. - The company aims to raise approximately 259.13 million yuan for projects related to radiation positioning and rehabilitation product headquarters, composite material production line upgrades, and research center construction [2]. Review and Inquiry - The review committee raised inquiries regarding the authenticity and reasonableness of Kolarity's collaboration with the American company Klarity, including the sustainability of using the "Klarity" trademark and the company's reliance on Klarity for sales channels [4]. - Questions were also posed about the sustainability of Kolarity's operating performance, particularly in light of healthcare cost control policies and market competition, as well as the company's competitive advantages in technology, funding, and scale [4].